| scholarly article | Q13442814 |
| P2093 | author name string | A Daugherty | |
| J W Heinecke | |||
| J L Dunn | |||
| D L Rateri | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase | Q24563459 | ||
| Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins | Q24564612 | ||
| Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase | Q24635143 | ||
| Studies on the chlorinating activity of myeloperoxidase | Q28235493 | ||
| Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages | Q28303116 | ||
| Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man | Q28359675 | ||
| Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits | Q28359752 | ||
| Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition | Q28625661 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
| Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions | Q33783079 | ||
| A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein | Q33836010 | ||
| Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 | ||
| Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation | Q33850346 | ||
| Myeloperoxidase-mediated inhibition of microbial respiration: damage to Escherichia coli ubiquinol oxidase | Q34042575 | ||
| Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid | Q34236440 | ||
| Minimally modified low density lipoprotein stimulates monocyte endothelial interactions | Q34248823 | ||
| Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. | Q34335341 | ||
| Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia | Q34340579 | ||
| Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros | Q34360883 | ||
| Oxygen-dependent microbial killing by phagocytes (first of two parts). | Q34381571 | ||
| Lipid peroxidation by human blood phagocytes | Q34466556 | ||
| Cell biology of arterial proteoglycans. | Q34496708 | ||
| Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent | Q34501431 | ||
| Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells | Q34526444 | ||
| Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture | Q34620804 | ||
| Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. | Q35817369 | ||
| A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies | Q36236863 | ||
| Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids | Q36263522 | ||
| Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins | Q36286282 | ||
| Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins | Q36376146 | ||
| Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells | Q36423053 | ||
| Cellular oxidative modification of low density lipoprotein does not require lipoxygenases | Q36759839 | ||
| Hydrogen peroxide metabolism in human monocytes during differentiation in vitro | Q37005256 | ||
| Unique autolytic cleavage of human myeloperoxidase. Implications for the involvement of active site MET409 | Q38323385 | ||
| Myeloperoxidase deficiency | Q39184783 | ||
| Characterization and quantification of the peroxidase in human monocytes | Q39207271 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| The subunit structure of crystalline canine myeloperoxidase | Q40089133 | ||
| Oxygen Metabolism and the Toxic Properties of Phagocytes | Q40122453 | ||
| Isolation procedure and some properties of myeloperoxidase from human leucocytes | Q40150278 | ||
| Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine | Q40343733 | ||
| Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells | Q41873727 | ||
| Induction of T-cell activation by oxidized low density lipoprotein | Q41940298 | ||
| HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization | Q42050958 | ||
| The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits | Q42115451 | ||
| Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages | Q42796812 | ||
| 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein | Q42862580 | ||
| Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits | Q43652291 | ||
| Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor | Q44775588 | ||
| Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits | Q46491747 | ||
| Oxidant membrane injury by the neutrophil myeloperoxidase system. II. Injury by stimulated neutrophils and protection by lipid-soluble antioxidants. | Q46590104 | ||
| Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. | Q54247314 | ||
| Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocytes | Q54301272 | ||
| Myeloperoxidase-catalyzed incorporation of amines into proteins: role of hypochlorous acid and dichloramines | Q67253835 | ||
| Peroxidase activity in monocytes and tissue macrophages of mice | Q67325651 | ||
| Possible involvement of myeloperoxidase in lipid peroxidation | Q67488286 | ||
| Modification of low density lipoproteins by sodium hypochlorite | Q67709484 | ||
| Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap | Q67852245 | ||
| Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits | Q67976682 | ||
| Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor | Q69635952 | ||
| CD antigens 1989 | Q69693094 | ||
| Role of superoxide in endothelial-cell modification of low-density lipoproteins | Q69819973 | ||
| Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic | Q69843470 | ||
| Evidence for and partial characterization of three major and three minor chromatographic forms of human neutrophil myeloperoxidase | Q70139453 | ||
| Crystallization and properties of myeloperoxidase from normal human leukocytes | Q70140290 | ||
| Superoxide initiates oxidation of low density lipoprotein by human monocytes | Q70164653 | ||
| Loss of granule myeloperoxidase during in vitro culture of human monocytes correlates with decay in antiprotozoa activity | Q70177765 | ||
| Antimicrobial activity of myeloperoxidase | Q70214734 | ||
| Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products | Q70328162 | ||
| Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation | Q70580559 | ||
| Myeloperoxidase of human leukaemic leucocytes. Oxidation of amino acids in the presence of hydrogen peroxide | Q70940747 | ||
| The reductive cleavage of myeloperoxidase in half, producing enzymically active hemi-myeloperoxidase | Q72887450 | ||
| Human eosinophil peroxidase: a novel isolation procedure, spectral properties and chlorinating activity | Q72890756 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 437-444 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions | |
| P478 | volume | 94 |
| Q37364258 | 2-Chlorohexadecanal and 2-chlorohexadecanoic acid induce COX-2 expression in human coronary artery endothelial cells |
| Q37366288 | 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima |
| Q28083260 | 3-nitrotyrosine modified proteins in atherosclerosis |
| Q44588212 | 8-Nitroxanthine, a product of myeloperoxidase, peroxynitrite, and activated human neutrophils, enhances generation of superoxide by xanthine oxidase |
| Q89228322 | A BODIPY Based Fluorescent Probe for the Rapid Detection of Hypochlorite |
| Q36250228 | A Highly Expressed Human Protein, Apolipoprotein B-100, Serves as an Autoantigen in a Subgroup of Patients With Lyme Disease |
| Q37669759 | A Janus Chelator Enables Biochemically Responsive MRI Contrast with Exceptional Dynamic Range |
| Q46639428 | A Ratiometric Fluorescent Probe Based on a Through-Bond Energy Transfer (TBET) System for Imaging HOCl in Living Cells |
| Q35562004 | A biochemical fluorometric method for assessing the oxidative properties of HDL. |
| Q38930883 | A fast-responsive mitochondria-targeted fluorescent probe detecting endogenous hypochlorite in living RAW 264.7 cells and nude mouse |
| Q53220935 | A fluorescent probe for hypochlorite based on the modulation of the unique rotation of the N-N single bond in acetohydrazide. |
| Q42679591 | A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages |
| Q45731096 | A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection |
| Q28544713 | A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL |
| Q36039153 | A highly selective and sensitive photoinduced electron transfer (PET) based HOCl fluorescent probe in water and its endogenous imaging in living cells |
| Q58860182 | A highly sensitive and rapidly responding fluorescent probe based on a rhodol fluorophore for imaging endogenous hypochlorite in living mice |
| Q46592840 | A highly specific BODIPY-based probe localized in mitochondria for HClO imaging |
| Q52723580 | A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients. |
| Q40637446 | A novel method of following oxidation of low-density lipoprotein using a sensitive fluorescent probe, diphenyl-1-pyrenylphosphine |
| Q39158525 | A ratiometric fluorescent probe based on a BODIPY-DCDHF conjugate for the detection of hypochlorous acid in living cells |
| Q38898049 | A ratiometric fluorescent probe for in situ quantification of basal mitochondrial hypochlorite in cancer cells. |
| Q39868162 | A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation |
| Q37089128 | A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL. |
| Q50202617 | A tumor-specific and mitochondria-targeted fluorescent probe for real-time sensing of hypochlorite in living cells |
| Q35044854 | A1M/α1-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation |
| Q36192289 | ABCA1 and atherosclerosis. |
| Q45297626 | Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. |
| Q33222417 | Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. |
| Q40394753 | Acrolein modifies apolipoprotein A-I in the human artery wall |
| Q33575669 | Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity |
| Q36906145 | Activation and silencing of matrix metalloproteinases |
| Q38052020 | Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. |
| Q31060150 | Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells |
| Q46710488 | Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome |
| Q36493881 | Alpha-chlorofatty Acid and coronary artery or aorta calcium scores in women with systemic lupus erythematosus. A pilot study. |
| Q38260171 | Alpha-chlorofatty acid accumulates in activated monocytes and causes apoptosis through reactive oxygen species production and endoplasmic reticulum stress |
| Q73762580 | Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein |
| Q84752654 | Aminobenzoic acid hydrazide, a myeloperoxidase inhibitor, alters the adhesive properties of neutrophils isolated from acute myocardial infarction patients |
| Q34543361 | An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients. |
| Q35466129 | An oxygen-induced but protein F-independent fibronectin-binding pathway in Streptococcus pyogenes. |
| Q36610126 | Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice |
| Q48969142 | Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain |
| Q28283086 | Antimicrobial reactive oxygen and nitrogen species: concepts and controversies |
| Q35757158 | ApoA-1 in Diabetes: Damaged Goods |
| Q37286296 | Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease |
| Q40637436 | Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid |
| Q36926660 | Assessing Human Health Risk to Endocrine Disrupting Chemicals: a Focus on Prenatal Exposures and Oxidative Stress |
| Q37608445 | Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium |
| Q42251021 | Association between serum myeloperoxidase levels and coronary artery disease in patients without diabetes, hypertension, obesity, and hyperlipidemia |
| Q50997002 | Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease. |
| Q42215707 | Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii |
| Q47878722 | Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme |
| Q37364334 | Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease |
| Q37172222 | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites |
| Q50927115 | Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study. |
| Q40418236 | Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action |
| Q41829508 | Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties |
| Q60924320 | Bases celulares y moleculares de la acumulación de colesterol en la pared vascular y su contribución a la progresión de la lesión aterosclerótica |
| Q73072515 | Beta-blockers inhibit the modification of low-density lipoproteins by sodium hypochlorite in vitro |
| Q92782717 | Binding of myeloperoxidase to the extracellular matrix of smooth muscle cells and subsequent matrix modification |
| Q36780282 | Biochemical and pathological studies on peroxidases -an updated review |
| Q37313946 | Biological markers of oxidative stress: Applications to cardiovascular research and practice |
| Q60924187 | Biología celular y molecular de las lesiones ateroscleróticas |
| Q34054210 | Biomarkers of myeloperoxidase-derived hypochlorous acid |
| Q41154272 | Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system |
| Q34310448 | Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation |
| Q46230315 | Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other |
| Q38344922 | Characterization and antioxidant properties of six Algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity |
| Q32062976 | Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36. |
| Q37549646 | Chlorinated Phospholipids and Fatty Acids: (Patho)physiological Relevance, Potential Toxicity, and Analysis of Lipid Chlorohydrins |
| Q33784503 | Chlorinated lipid species in activated human neutrophils: lipid metabolites of 2-chlorohexadecanal |
| Q58762763 | Chlorination and oxidation of human plasma fibronectin by myeloperoxidase-derived oxidants, and its consequences for smooth muscle cell function |
| Q59807449 | Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase |
| Q46256505 | Chlorinative stress in age-related diseases: a literature review |
| Q34074664 | Chlorotyrosine promotes human aortic smooth muscle cell migration through increasing superoxide anion production and ERK1/2 activation |
| Q46689320 | Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis |
| Q43655175 | Citrus flavanones affect hepatic fatty acid oxidation in rats by acting as prooxidant agents |
| Q26785512 | Clinical Relevance of Biomarkers of Oxidative Stress |
| Q33598770 | Clinical significance of the humoral immune response to modified LDL. |
| Q35062312 | Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis? |
| Q35153774 | Clonal analysis of hematopoietic progenitor cells in the zebrafish |
| Q37358413 | Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma |
| Q47739511 | Colocalization of iron and ceroid in human atherosclerotic lesions |
| Q72999605 | Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation |
| Q77161290 | Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis |
| Q62125033 | Cross-sectional correlates of myeloperoxidase and alpha-1-acid glycoprotein with adiposity, atherogenic and hematological indices in metabolic syndrome patients with or without diabetes |
| Q77907848 | Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues |
| Q43002718 | Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques |
| Q46611633 | Development and sensing applications of fluorescent motifs within the mitochondrial environment |
| Q59704191 | Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein |
| Q90092715 | Differential effects of Th17 cytokines during the response of neutrophils to Burkholderia cenocepacia outer membrane protein A |
| Q46796686 | Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation |
| Q34342725 | Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons |
| Q34758389 | Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl. |
| Q41528800 | Distinct infiltration of neutrophils in lesion shoulders in ApoE-/- mice. |
| Q41432893 | Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions? |
| Q39859430 | Dose-dependent transitions in Nrf2-mediated adaptive response and related stress responses to hypochlorous acid in mouse macrophages |
| Q35167895 | Dual functionality of myeloperoxidase in rotenone-exposed brain-resident immune cells. |
| Q38577283 | Dysfunctional HDL and atherosclerotic cardiovascular disease |
| Q33604003 | Dysfunctional HDL as a diagnostic and therapeutic target |
| Q26774903 | Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics |
| Q28287127 | Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors |
| Q43964246 | Effect of acetaminophen on the myeloperoxidase-hydrogen peroxide-nitrite mediated oxidation of LDL. |
| Q50913860 | Effect of ascophyllan from brown algae Padina tetrastromatica on inflammation and oxidative stress in carrageenan-induced rats. |
| Q34515851 | Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model |
| Q37301032 | Effects of copper sulfate-oxidized or myeloperoxidase-modified LDL on lipid loading and programmed cell death in macrophages under hypoxia |
| Q43777199 | Effects of hypochlorous acid on unsaturated phosphatidylcholines |
| Q46012541 | Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart. |
| Q28344995 | Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions |
| Q33723943 | Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects |
| Q89775678 | Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis |
| Q28366645 | Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration |
| Q73176780 | Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO(-)) |
| Q46540013 | Enhanced Fluorescence Turn-on Imaging of Hypochlorous Acid in Living Immune and Cancer Cells |
| Q24311407 | Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers |
| Q33816483 | Enhanced tyrosine nitration of prostacyclin synthase is associated with increased inflammation in atherosclerotic carotid arteries from type 2 diabetic patients |
| Q42543316 | Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques |
| Q33919164 | Eosinophil-dependent bromination in the pathogenesis of asthma |
| Q90055412 | Evaluation of reproductive and renal toxicity of varenicline in male rats |
| Q43200073 | Evaluation of the cardiovascular effects of varenicline in rats. |
| Q42991232 | Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque |
| Q41842014 | Evidence of inflammatory cell involvement in brain arteriovenous malformations |
| Q33897950 | Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins |
| Q40030728 | Exposure of aconitase to smoking-related oxidants results in iron loss and increased iron response protein-1 activity: potential mechanisms for iron accumulation in human arterial cells |
| Q34313976 | Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis |
| Q91661911 | Feasibility of a plasma bioassay to assess oxidative protection of low-density lipoproteins by high-density lipoproteins |
| Q45811598 | Fluorescent hydroxylamine derived from the fragmentation of PAMAM dendrimers for intracellular hypochlorite recognition. |
| Q30743600 | Formation of lysophospholipids from unsaturated phosphatidylcholines under the influence of hypochlorous acid |
| Q46943421 | Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils |
| Q41978147 | Fragmentation of extracellular matrix by hypochlorous acid |
| Q37894551 | Generation and detection of levuglandins and isolevuglandins in vitro and in vivo. |
| Q36461073 | Genetic markers of oxidative stress and coronary atherosclerosis |
| Q38311723 | Genetic variants of myeloperoxidase and lung cancer risk |
| Q40137109 | Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages |
| Q34578402 | Growing significance of myeloperoxidase in non-infectious diseases. |
| Q35120941 | HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function |
| Q37367671 | HDL, lipid peroxidation, and atherosclerosis |
| Q28535779 | HDL-apoA-I exchange: rapid detection and association with atherosclerosis |
| Q42505831 | HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide |
| Q34119124 | High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis |
| Q33817228 | High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences |
| Q36002630 | High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 |
| Q38220761 | High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease |
| Q34455031 | Homocysteine and cardiovascular disease in diabetes mellitus |
| Q28479210 | Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis |
| Q45005902 | Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species |
| Q47975180 | Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase |
| Q37359571 | Human neutrophils employ chlorine gas as an oxidant during phagocytosis |
| Q37363040 | Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsatu |
| Q34066009 | Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize alpha-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway |
| Q43650867 | Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I. |
| Q44008156 | Human neutrophils oxidize low-density lipoprotein by a hypochlorous acid-dependent mechanism: the role of vitamin C. |
| Q35764845 | Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems |
| Q33825419 | Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase |
| Q43647810 | Hypochlorite induces the formation of LDL(-), a potentially atherogenic low density lipoprotein subspecies |
| Q40945169 | Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages |
| Q44643196 | Hypochlorite-Mediated Fragmentation of Hyaluronan, Chondroitin Sulfates, and RelatedN-Acetyl Glycosamines: Evidence for Chloramide Intermediates, Free Radical Transfer Reactions, and Site-Specific Fragmentation |
| Q41952132 | Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation |
| Q53854794 | Hypochlorite-induced damage to red blood cells: evidence for the formation of nitrogen-centred radicals. |
| Q42993746 | Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation |
| Q44031789 | Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport |
| Q40795530 | Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro |
| Q39585678 | Hypochlorite-modified high-density lipoprotein promotes induction of HO-1 in endothelial cells via activation of p42/44 MAPK and zinc finger transcription factor Egr-1. |
| Q43559341 | Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase |
| Q74445963 | Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells |
| Q41289645 | Hypochlorous acid and its pharmacological antagonism: an update picture |
| Q37446863 | Hypochlorous acid converts the gamma-glutamyl group of glutathione disulfide to 5-hydroxybutyrolactam, a potential marker for neutrophil activation |
| Q44448828 | Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation |
| Q43726485 | Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase |
| Q28478114 | Hypochlorous acid-induced heme degradation from lactoperoxidase as a novel mechanism of free iron release and tissue injury in inflammatory diseases |
| Q37406247 | Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival |
| Q43897071 | Hypochlorous acid-modified low-density lipoprotein inactivates the lysosomal protease cathepsin B: protection by ascorbic and lipoic acids |
| Q34528130 | Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins |
| Q37340646 | Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions. |
| Q48615832 | Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis |
| Q77505427 | Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis |
| Q35747219 | Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver |
| Q43640428 | Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes |
| Q35764605 | Immunological evidence for hypochlorite-modified proteins in human kidney |
| Q35166941 | Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway |
| Q37665476 | Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. |
| Q28350068 | Increased atherosclerosis in myeloperoxidase-deficient mice |
| Q38083555 | Inflammation and immune system interactions in atherosclerosis |
| Q35739814 | Inflammatory and oxidative markers in atherosclerosis: relationship to outcome |
| Q43202739 | Inflammatory proteins on HDL: what are we measuring? |
| Q28395876 | Inhaled matters of the heart |
| Q34155186 | Inhibition of hypochlorous acid-induced cellular toxicity by nitrite |
| Q44395889 | Inhibition of hypochlorous acid-induced oxidative reactions by nitrite: is nitrite an antioxidant? |
| Q40865183 | Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line. |
| Q34478086 | Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases. |
| Q90378589 | Iodide modulates protein damage induced by the inflammation-associated heme enzyme myeloperoxidase |
| Q57185465 | Isolevuglandins and Cardiovascular Disease |
| Q59400065 | Kinetics and Thermodynamics of Halide and Nitrite Oxidation by Mammalian Heme Peroxidases |
| Q73923990 | Kinetics of tryptophan oxidation in plasma lipoproteins by myeloperoxidase-generated HOCl |
| Q34249723 | Linoleic acid hydroperoxide reacts with hypochlorous acid, generating peroxyl radical intermediates and singlet molecular oxygen |
| Q42615245 | Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia |
| Q37951442 | Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis |
| Q36228526 | Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander? |
| Q37707415 | Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker |
| Q37337498 | Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins |
| Q35751034 | Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques |
| Q43943413 | Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized. |
| Q41615081 | Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis |
| Q37091275 | Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. |
| Q38619292 | Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction |
| Q54201614 | Lyme Disease-Associated IgG4 Autoantibodies Correlate with Synovial Pathology in Antibiotic-Refractory Lyme Arthritis. |
| Q33195740 | Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein |
| Q28359694 | Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes |
| Q22253929 | Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species |
| Q37936512 | Mechanisms and consequences of oxidative damage to extracellular matrix. |
| Q37785293 | Mechanisms of LDL oxidation |
| Q33603019 | Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders |
| Q38060209 | Metabolomics and ischaemic heart disease. |
| Q36858466 | Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. |
| Q52688145 | Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation. |
| Q98726639 | MicroRNA sequences modulating inflammation and lipid accumulation in macrophage "foam" cells: Implications for atherosclerosis |
| Q46888536 | Mitochondria-targeted colorimetric and fluorescent probes for hypochlorite and their applications for in vivo imaging |
| Q77907835 | Modification of proteins and lipids by myeloperoxidase |
| Q33897803 | Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway |
| Q92383461 | Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex |
| Q33473042 | Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques |
| Q50912369 | Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease. |
| Q46808193 | Myeloperoxidase activity imaging using (67)Ga labeled substrate |
| Q37393355 | Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway |
| Q36014190 | Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction |
| Q41879141 | Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflamed liver |
| Q46900591 | Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans |
| Q73378050 | Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis |
| Q41880909 | Myeloperoxidase deficiency preserves vasomotor function in humans |
| Q52629638 | Myeloperoxidase derived oxidants damage artery wall proteins in an animal model of chronic kidney disease accelerated atherosclerosis. |
| Q36302434 | Myeloperoxidase evokes substantial vasomotor responses in isolated skeletal muscle arterioles of the rat. |
| Q54764581 | Myeloperoxidase gene variation as a determinant of atherosclerosis progression in the abdominal and thoracic aorta: an autopsy study. |
| Q46834806 | Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages |
| Q46960352 | Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. |
| Q64077636 | Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition |
| Q57414500 | Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study |
| Q35564735 | Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice |
| Q22254048 | Myeloperoxidase is involved in H2O2-induced apoptosis of HL-60 human leukemia cells |
| Q41896945 | Myeloperoxidase is not useful for detecting stress inducible myocardial ischemia but may be indicative of the severity of coronary artery disease |
| Q34072878 | Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina |
| Q35541075 | Myeloperoxidase modulation by LDL apheresis in familial hypercholesterolemia |
| Q44485540 | Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome |
| Q34791672 | Myeloperoxidase produces nitrating oxidants in vivo |
| Q37992526 | Myeloperoxidase production by macrophage and risk of atherosclerosis |
| Q35838851 | Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions |
| Q34291776 | Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein |
| Q37353408 | Myeloperoxidase, modified lipoproteins, and atherogenesis |
| Q42842899 | Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men |
| Q42502848 | Myeloperoxidase-dependent generation of hypochlorite-modified proteins in human placental tissues during normal pregnancy |
| Q37078673 | Myeloperoxidase-derived oxidants inhibit sarco/endoplasmic reticulum Ca2+-ATPase activity and perturb Ca2+ homeostasis in human coronary artery endothelial cells |
| Q39255171 | Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl). |
| Q34162955 | Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention |
| Q34006268 | Myeloperoxidase-generated oxidants and atherosclerosis |
| Q33852491 | Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro |
| Q28200597 | Myeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (-)-epicatechin |
| Q35536293 | Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I. |
| Q51204343 | Myeloperoxidase-mediated protein lysine oxidation generates 2-aminoadipic acid and lysine nitrile in vivo. |
| Q36860606 | Myeloperoxidase: a target for new drug development? |
| Q34545509 | Myeloperoxidase: a therapeutic target for preventing insulin resistance and the metabolic sequelae of obesity? |
| Q33729198 | Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein |
| Q42255196 | Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy |
| Q36296514 | N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients |
| Q100568733 | NET-associated citrullinated histones promote LDL aggregation and foam cell formation in vitro |
| Q41996261 | Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL) |
| Q36624064 | Native low density lipoprotein promotes lipid raft formation in macrophages |
| Q34339353 | Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages |
| Q38648056 | Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease |
| Q38628708 | Neutrophil's weapons in atherosclerosis |
| Q42700363 | Neutrophils, Hypercholesterolemia, and Atherogenesis |
| Q36088357 | New biomarkers for primary mitral regurgitation |
| Q35106766 | New insights into the effects of the protein moiety of oxidized LDL (oxLDL) |
| Q28645799 | Nitric oxide is a physiological substrate for mammalian peroxidases |
| Q84320607 | Nitrite, a reactive nitrogen species, protects human alpha-2-macroglobulin from halogenated oxidant, HOCl |
| Q78099814 | Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein |
| Q53090374 | Oral administration of alkaloid fraction from Ruta graveolens inhibits oxidative stress and inflammation in hypercholesterolemic rabbits. |
| Q58581080 | Overriding Phthalate Decomposition When Exploring Mycophenolic Acid Intermediates as Selenium-Based ROS Biological Probes |
| Q77718601 | Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis |
| Q38209427 | Oxidation and modification of extracellular matrix and its role in disease |
| Q33902023 | Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export |
| Q73110368 | Oxidation of heparin-treated low density lipoprotein by peroxidases |
| Q33963758 | Oxidation of low-density lipoprotein by hemoglobin-hemichrome. |
| Q46269480 | Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets. |
| Q45114412 | Oxidative modification of low-density lipoprotein: lipid peroxidation by myeloperoxidase in the presence of nitrite |
| Q73370736 | Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCL in vitro |
| Q33554184 | Oxidative risk for atherothrombotic cardiovascular disease |
| Q37501271 | Oxidative stress and cardiovascular disease: novel tools give (free) radical insight |
| Q33822180 | Oxidative stress and cellular immunity in patients with recurrent aphthous ulcers |
| Q36905196 | Oxidative stress and endothelial dysfunction in vascular disease |
| Q35088524 | Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis |
| Q73407786 | Oxidative tyrosylation of high density lipoprotein impairs biliary sterol secretion in rats |
| Q34658022 | Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress |
| Q77910747 | Oxysterols and atherosclerosis |
| Q40343992 | Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases |
| Q43089504 | Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice |
| Q33610044 | Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules |
| Q60998579 | Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS |
| Q44249438 | Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits |
| Q39034108 | Pentoxifylline Inhibits Epidural Fibrosis in Post-Laminectomy Rats. |
| Q44688340 | Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism |
| Q34191993 | Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue |
| Q44394291 | Phospholipid chlorohydrins cause ATP depletion and toxicity in human myeloid cells |
| Q57947449 | Plasma oxidized high-density lipoprotein and glycated apolipoprotein A-I concentrations in ST-segment elevation myocardial infarction patients with stress hyperglycaemia or high thrombus burden |
| Q44159839 | Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers |
| Q38095369 | Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? |
| Q51032319 | Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease. |
| Q37770003 | Potential for chlorine gas-induced injury in the extrapulmonary vasculature. |
| Q36176582 | Potential role of plasma myeloperoxidase level in predicting long-term outcome of acute myocardial infarction |
| Q36484657 | Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis |
| Q37353371 | Presence of hypochlorite-modified proteins in human atherosclerotic lesions |
| Q45275694 | Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate. |
| Q31628322 | Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation |
| Q40281726 | Proliferation of macrophages due to the inhibition of inducible nitric oxide synthesis by oxidized low-density lipoproteins. |
| Q74484834 | Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro |
| Q26827410 | Protein carbamylation and cardiovascular disease |
| Q53226236 | Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. |
| Q36058528 | Protein-bound acrolein: potential markers for oxidative stress |
| Q35581112 | Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study |
| Q89503367 | Randomized clinical trial of the effect of intraoperative humidified carbon dioxide insufflation in open laparotomy for colorectal resection |
| Q30372838 | Rational drug design applied to myeloperoxidase inhibition. |
| Q36118999 | Reactive Oxygen Species Donors Increase the Responsiveness of Dorsal Horn Neurons and Induce Mechanical Hyperalgesia in Rats |
| Q35165194 | Reactive oxygen species in cardiovascular disease. |
| Q37361893 | Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability |
| Q42995934 | Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-I. |
| Q45338276 | Redox Regulation of Inflammatory Processes Is Enzymatically Controlled. |
| Q35576288 | Redox properties of myeloperoxidase |
| Q46305715 | Regulation and function of endothelial glycocalyx layer in vascular diseases |
| Q54587897 | Relation of myeloperoxidase promoter polymorphism and long-term hormone replacement therapy to oxidized low-density lipoprotein autoantibodies in postmenopausal women. |
| Q42089083 | Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. |
| Q37838428 | Reno-cerebrovascular disease: linking the nephron and neuron |
| Q42807176 | Rhodamine-modified upconversion nanophosphors for ratiometric detection of hypochlorous acid in aqueous solution and living cells. |
| Q36229648 | Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis? |
| Q37798811 | Role of Myeloperoxidase in Cardiology |
| Q24683780 | Role of oxidants in microbial pathophysiology |
| Q37045445 | Role of oxidative stress and nitric oxide in atherothrombosis |
| Q34006248 | Role of reactive aldehyde in cardiovascular diseases |
| Q42931100 | S100A12 links to thoracic aortic aneurysms |
| Q61978281 | Salicylate promotes myeloperoxidase-initiated LDL oxidation: antagonization by its metabolite gentisic acid |
| Q45078277 | Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-San |
| Q41937076 | Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins |
| Q27690671 | Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function |
| Q45800383 | Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome. |
| Q42737190 | Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome |
| Q89881813 | Site-specific 5-hydroxy-tryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high density lipoprotein biogenesis |
| Q35783321 | Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q44166458 | Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases |
| Q37173205 | The HDL proteome: a marker--and perhaps mediator--of coronary artery disease |
| Q90449141 | The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Protects Vascular Endothelial Function in Hypercholesterolemic Rats by Inhibiting Myeloperoxidase |
| Q63978868 | The Resurrection of Myeloperoxidase as a Therapeutic Target: Is it Lazarus or Just an Apparition? |
| Q49603161 | The chlorinated lipidome originating from myeloperoxidase-derived HOCl targeting plasmalogens: Metabolism, clearance, and biological properties |
| Q40271950 | The critical role of myeloperoxidase in Streptococcus pneumoniae clearance and tissue damage during mouse acute otitis media |
| Q50496523 | The effect of certain steroid hormones on the expression of genes involved in the metabolism of free radicals. |
| Q35697554 | The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands |
| Q42137439 | The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice |
| Q34986351 | The macrophage foam cell as a target for therapeutic intervention |
| Q34347558 | The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings |
| Q24656816 | The molecular mechanisms of the thrombotic complications of atherosclerosis |
| Q37512515 | The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport |
| Q33853348 | The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation |
| Q41146808 | The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice |
| Q28396048 | The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states |
| Q39906664 | The proper study of mankind |
| Q37205406 | The reaction of HOCl and cyanocobalamin: corrin destruction and the liberation of cyanogen chloride. |
| Q24629974 | The response-to-retention hypothesis of early atherogenesis |
| Q37631070 | The role of hypothiocyanous acid (HOSCN) in biological systems. |
| Q37291868 | The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department |
| Q37049625 | The role of myeloperoxidase in HDL oxidation and atherogenesis |
| Q37275296 | The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. |
| Q34319485 | The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease |
| Q35157613 | The role of vitamin E in atherosclerosis |
| Q38065232 | The roles of garlic on the lipid parameters: a systematic review of the literature |
| Q30240734 | The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture. |
| Q40617645 | The state of macrophage differentiation determines the TNFα response to nitrated lipoprotein uptake |
| Q36052967 | The use of myeloperoxidase as a risk marker for atherosclerosis |
| Q36182725 | Thematic review series: The immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis |
| Q53394627 | Titanium dioxide as a catalyst support in heterogeneous catalysis. |
| Q46071984 | Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males |
| Q36386406 | Tripping up Trp: Modification of protein tryptophan residues by reactive oxygen species, modes of detection, and biological consequences |
| Q46842392 | Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species |
| Q73853371 | Urate attenuates oxidation of native low-density lipoprotein by hypochlorite and the subsequent lipoprotein-induced respiratory burst activities of polymorphonuclear leukocytes |
| Q24559986 | Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle |
| Q37142318 | Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high-density lipoprotein oxidized by myeloperoxidase. |
| Q37392502 | VPO1 mediates oxidation of LDL and formation of foam cells |
| Q60047032 | Vascular Oxidative Stress: Impact and Therapeutic Approaches |
| Q41998801 | Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein |
| Q41769762 | When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid |
| Q74465119 | pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque |
Search more.